| Missing Links? Citation Matrix | Graphs | Glossary HistCite Guide About |
Nodes: 247,
Authors: 417,
Journals: 90,
Outer References: 3529,
Words: 771
Collection span: 1977 - 2005
View: Overview. Sorted by date.
Page 3 of 3: [ 1 2 3 ]
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
|---|---|---|---|---|---|
| 201 | 6 | 62 | 215 2002 JAN-FEB [JAN 15] JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION 9 (1): 2-9 Sood AK; Fletcher MS; Hendrix MJC The embryonic-like properties of aggressive human tumor cells | 2 | 15 |
| 202 | 4 | 30 | 206 2002 FEB 1 CANCER RESEARCH 62 (3): 665-668 Hendrix MJC; Seftor REB; Seftor EA; Gruman LM; Lee LML; et al. Transendothelial function of human metastatic melanoma cells: Role of the microenvironment in cell-fate determination | 7 | 24 |
| 203 | 7 | 48 | 218 2002 FEB 15 PROSTATE 50 (3): 189-201 Sharma N; Seftor REB; Seftor EA; Gruman LM; Heidger PM; et al. Prostatic tumor cell plasticity involves cooperative interactions of distinct phenotypic subpopulations: Role in vasculogenic mimicry | 7 | 23 |
| 204 | 0 | 0 | 213 2002 MAR [15] JOURNAL OF DENTAL RESEARCH 81: A213-A213 Schneider GB; Kurago Z; Zaharias R; Gruman LM; Schaller M; et al. Elevated focal adhesion kinase expression facilitates oral tumor cell invasion. | 0 | 0 |
| 205 | 0 | 0 | 212 2002 MAR 22 FASEB JOURNAL 16 (5): A1249-A1249 Hess AR; Seftor EA; Gruman LM; Seftor REB; Hendrix MJC Molecular dissection of vasculogenic mimicry displayed by highly aggressive human melanoma tumor cells | 0 | 0 |
| 206 | 5 | 27 | 217 2002 APR [15] PLACENTA 23 (4): 274-280 Dokras A; Gardner LMG; Kirschmann DA; Seftor EA; Hendrix MJC The tumour suppressor gene maspin is differentially regulated in cytotrophoblasts during human placental development | 1 | 4 |
| 207 | 0 | 10 | 219 2002 MAY 24 SCIENCE 296 (5572): 1401-1402 Korn D; Rich RR; Garrison HH; Golub SH; Hendrix MJC; et al. Science policy - The NIH budget in the "postdoubting" era | 0 | 9 |
| 208 | 8 | 69 | 208 2002 [JUN 30] CLINICAL & EXPERIMENTAL METASTASIS 19 (3): 233-246 Seftor EA; Meltzer PS; Kirschmann DA; Pe'er J; Maniotis AJ; et al. Molecular determinants of human uveal melanoma invasion and metastasis | 8 | 21 |
| 209 | 4 | 14 | 200 2002 JUL 26 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 295 (4): 800-805 Odero-Marah VA; Khalkhali-Ellis Z; Schneider GB; Seftor EA; Seftor REB; et al. Tyrosine phosphorylation of maspin in normal mammary epithelia and breast cancer cells | 2 | 6 |
| 210 | 6 | 56 | 207 2002 AUG 1 CANCER RESEARCH 62 (15): 4478-4483 Kirschmann DA; Seftor EA; Fong SFT; Nieva DRC; Sullivan CM; et al. A molecular role for lysyl oxidase in breast cancer invasion | 0 | 12 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 211 | 2 | 50 | 203 2002 SEP-OCT [SEP 15] CANCER BIOLOGY & THERAPY 1 (5): 511-517 Sood AK; Coffin J; Jabbari S; Buller RE; Hendrix MJC; et al. p53 null mutations are associated with a telomerase negative phenotype in ovarian carcinoma | 1 | 7 |
| 212 | 0 | 0 | 204 2002 SEP-OCT [SEP 15] CANCER BIOLOGY & THERAPY 1 (5): 568-570 Hendrix MJC Research philosophy - philosophical views - The changing complexion of America's academic research enterprise | 0 | 0 |
| 213 | 7 | 30 | 209 2002 SEP [15] CLINICAL CANCER RESEARCH 8 (9): 2924-2932 Sood AK; Fletcher MS; Gruman LM; Coffin JE; Jabbari S; et al. The paradoxical expression of maspin in ovarian carcinoma | 4 | 32 |
| 214 | 1 | 15 | 214 2002 SEP [15] JOURNAL OF RHEUMATOLOGY 29 (9): 1843-1846 Khalkhali-Ellis Z; Handa RJ; Price RH; Adams BD; Callaghan JJ; et al. Androgen receptors in human synoviocytes and androgen regulation of interleukin 1 beta (1L-1 beta) induced IL-6 production: A link between hypoandrogenicity and rheumatoid arthritis? | 0 | 0 |
| 215 | 0 | 20 | 210 2002 OCT [15] CLINICAL CANCER RESEARCH 8 (10): 3193-3197 Cooper BC; Ritchie JM; Broghammer CLW; Coffin J; Sorosky JI; et al. Preoperative serum vascular endothelial growth factor levels: Significance in ovarian cancer | 0 | 10 |
| 216 | 7 | 54 | 211 2002 OCT [15] CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 44 (1): 17-27 Seftor EA; Meltzer PS; Schatteman GC; Gruman LM; Hess AR; et al. Expression of multiple molecular phenotypes by aggressive melanoma tumor cells: role in vasculogenic mimicry | 3 | 8 |
| 217 | 9 | 24 | 205 2002 NOV-DEC [NOV 15] CANCER BIOLOGY & THERAPY 1 (6): 661-664 Sood AK; Fletcher MS; Zahn CM; Gruman LM; Coffin JE; et al. The clinical significance of tumor cell-lined vasculature in ovarian carcinoma - Implications for anti-vasculogenic therapy | 1 | 2 |
| 218 | 8 | 24 | 216 2002 NOV [15] MOLECULAR CANCER THERAPEUTICS 1 (13): 1173-1179 Seftor REB; Seftor EA; Kirschmann DA; Hendrix MJC Targeting the tumor microenvironment with chemically modified tetracyclines: Inhibition of laminin 5 gamma 2 chain promigratory fragments and vasculogenic mimicry | 4 | 6 |
| 219 | 2 | 38 | 201 2002 DEC 15 CANCER 95 (12): 2508-2515 Schneider GB; Kurago Z; Zaharias R; Gruman LM; Schaller MD; et al. Elevated focal adhesion kinase expression facilitates oral tumor cell invasion | 0 | 12 |
| 220 | 0 | 0 | 229 2003 FEB [15] JOURNAL OF INVESTIGATIVE MEDICINE 51: S131-S131 O'Meara MM; Stea B; Rennels M; Lu D; Domann F; et al. Loss of maspin expression in ductal carcinoma in situ of the breast. | 0 | 0 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 221 | 0 | 0 | 230 2003 MAR [15] JOURNAL OF INVESTIGATIVE MEDICINE 51: S363-S363 O'Meara MM; Stea B; Rennels M; Lu D; Domann F; et al. Loss of maspin expression in ductal carcinoma in situ of the breast | 0 | 0 |
| 222 | 1 | 1 | 231 2003 MAR [15] JOURNAL OF UROLOGY 169 (3): 1134-1134 Hendrix MJC Editorial: The potential clinical use of exploiting metastasis suppressor genes to regulate prostatic cancer | 0 | 1 |
| 223 | 0 | 0 | 226 2003 MAR 17 FASEB JOURNAL 17 (5): A1165-A1165 Hendrix MJC; Seftor EA; Weiss RM; Kirschmann DA; Gruman LM; et al. Plasticity allows vasculogenic mimicry by melanoma tumor cells | 0 | 0 |
| 224 | 0 | 0 | 227 2003 MAR 17 FASEB JOURNAL 17 (5): A1175-A1175 Chunthapong J; Seftor E; Khalkhali-Ellis Z; Sullivan CM; Hendrix MJC; et al. E-cadherin signaling in prostate cancer | 0 | 0 |
| 225 | 0 | 0 | 228 2003 MAR 17 FASEB JOURNAL 17 (5): A1347-A1347 Sennoune S; Chua-Tuan J; Bakunts K; Martinez GM; Seftor EA; et al. Plasmalemmal vacuolar type H+-ATPasc (pmV-ATPase) is involved in the decreased of the tumor progression in a diabetic model | 0 | 0 |
| 226 | 5 | 74 | 220 2003 APR [15] AMERICAN JOURNAL OF PATHOLOGY 162 (4): 1037-1042 Walker-Daniels J; Hess AR; Hendrix MJC; Kinch MS Differential regulation of EphA2 in normal and malignant cells | 0 | 15 |
| 227 | 5 | 27 | 221 2003 MAY [15] AMERICAN JOURNAL OF PATHOLOGY 162 (5): 1411-1417 Khalkhali-Ellis Z; Hendrix MJC Nitric oxide regulation of maspin expression in normal mammary epithelial and breast cancer cells | 1 | 4 |
| 228 | 5 | 27 | 222 2003 MAY-JUN [MAY 15] CANCER BIOLOGY & THERAPY 2 (3): 257-258 Sood AK; Hendrix MJC The complexity of tumor vascularity | 0 | 3 |
| 229 | 7 | 45 | 233 2003 MAY 19 ONCOGENE 22 (20): 3070-3075 Hendrix MJC; Seftor EA; Hess AR; Seftor REB Molecular plasticity of human melanoma cells | 0 | 12 |
| 230 | 13 | 119 | 232 2003 JUN [15] NATURE REVIEWS CANCER 3 (6): 411-421 Hendrix MJC; Seftor EA; Hess AR; Seftor REB Vasculogenic mimicry and tumour-cell plasticity: Lessons from melanoma | 3 | 29 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 231 | 8 | 34 | 234 2003 [JUN 30] TISSUE REMODELING 995: 151-161 Hendrix MJC; Seftor EA; Kirschmann DA; Quaranta V; Seftor REB Remodeling of the microenvironment by aggressive melanoma tumor cells | 0 | 6 |
| 232 | 6 | 34 | 223 2003 JUL-AUG [JUL 15] CANCER BIOLOGY & THERAPY 2 (4): 398-403 Odero-Marah VA; Khalkhali-Ellis Z; Chunthapong J; Amir S; Seftor REB; et al. Maspin regulates different signaling pathways for motility and adhesion in aggressive breast cancer cells | 0 | 2 |
| 233 | 11 | 44 | 224 2003 AUG 15 CANCER RESEARCH 63 (16): 4757-4762 Hess AR; Seftor EA; Seftor REB; Hendrix MJC Phosphoinositide 3-kinase regulates membrane type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry | 0 | 9 |
| 234 | 11 | 61 | 225 2003 SEP 1 CANCER RESEARCH 63 (17): 5381-5389 Ruf W; Seftor EA; Petrovan RJ; Weiss RM; Gruman LM; et al. Differential role of tissue factor pathway inhibitors 1 and 2 in melanoma vasculogenic mimicry | 0 | 4 |
| 235 | 5 | 25 | 237 2004 JAN 15 CLINICAL CANCER RESEARCH 10 (2): 449-454 Khalkhali-Ellis Z; Christian AL; Kirschmann DA; Edwards EM; Rezaie-Thompson M; et al. Regulating the tumor suppressor gene maspin in breast cancer cells: A potential mechanism for the anticancer properties of tamoxifen | 0 | 2 |
| 236 | 0 | 0 | 244 2004 FEB [15] JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION 11 (2): 181A-181A Sood AK; Coffin JE; Schneider GB; Fletcher MS; DeYoung BR; et al. Role of FAK in ovarian cancer invasion and migration. | 0 | 0 |
| 237 | 5 | 42 | 241 2004 MAR 1 JOURNAL OF CELLULAR BIOCHEMISTRY 91 (4): 649-661 Chunthapong J; Seftor EA; Khalkhali-Ellis Z; Seftor REB; Amir S; et al. Dual roles of E-cadherin in prostate cancer invasion | 0 | 2 |
| 238 | 0 | 0 | 238 2004 MAR 23 FASEB JOURNAL 18 (4): A21-A21 Hendrix MJC; Seftor EA; Meltzer PS; Kirschmann DA; Margaryan NV; et al. The epigenetic effect of the tumor cell microenvironment on the transdifferentiation potential of melanoma cells | 0 | 0 |
| 239 | 0 | 0 | 239 2004 MAR 23 FASEB JOURNAL 18 (4): A416-A416 Chunthapong J; Lubaroff DM; Hendrix MJC; Heidger PM Morphological and biological characterization of selected DU145 human prostate cancer cell subpopulations | 0 | 0 |
| 240 | 13 | 69 | 235 2004 APR [15] AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY 190 (4): 899-909 Sood AK; Fletcher MS; Coffin JE; Yang M; Seftor EA; et al. Functional role of matrix metalloproteinases in ovarian tumor cell plasticity | 0 | 0 |
| # | LCR | NCR | Node / Date / Journal / Author | LCS | GCS |
| 241 | 2 | 30 | 240 2004 JUL 7 GENE 336 (1): 37-46 Norwood LE; Grade SK; Cryderman DE; Hines KA; Furiasse N; et al. Conserved properties of HP1(Hs alpha) | 0 | 1 |
| 242 | 6 | 38 | 246 2004 JUL-AUG [JUL 15] NEOPLASIA 6 (4): 380-389 Futscher BW; O'Meara MM; Kim CJ; Rennels MA; Lu D; et al. Aberrant methylation of the maspin promoter is an early event in human breast cancer | 0 | 2 |
| 243 | 2 | 26 | 245 2004 AUG [15] MOLECULAR CANCER THERAPEUTICS 3 (8): 895-902 Qin JZ; Stennet L; Bacon P; Bodner B; Hendrix MJC; et al. p53-independent NOXA induction overcomes apoptotic resistance of malignant melanomas | 0 | 0 |
| 244 | 5 | 30 | 243 2004 OCT 6 JOURNAL OF THE NATIONAL CANCER INSTITUTE 96 (19): 1473-1477 van der Schaft DWJ; Seftor REB; Seftor EA; Hess AR; Gruman LM; et al. Effects of angiogenesis inhibitors on vascular network formation by human endothelial and melanoma cells | 0 | 1 |
| 245 | 3 | 52 | 236 2004 OCT [15] AMERICAN JOURNAL OF PATHOLOGY 165 (4): 1087-1095 Sood AK; Coffin JE; Schneider GB; Fletcher MS; DeYoung BR; et al. Biological significance of focal adhesion kinase in ovarian cancer - Role in migration and invasion | 0 | 1 |
| 246 | 0 | 41 | 242 2004 NOV [15] JOURNAL OF CELLULAR PHYSIOLOGY 201 (2): 190-200 Rojas JD; Sennoune SR; Martinez GM; Bakunts K; Meininger CJ; et al. Plasmalemmal vacuolar H+-ATPase is decreased in microvascular endothelial cells from a diabetic model | 0 | 0 |
| 247 | 0 | 12 | 247 2005 JAN [15] JOURNAL OF THE MEDICAL LIBRARY ASSOCIATION 93 (1): 16-20 D'Allesandro MP; D'Alessandro DM; Bakalar RS; Ashley DE; Hendrix MJC The Virtual Naval Hospital: the digital library as knowledge management tool for nomadic patrons | 0 | 0 |